glp-1 anorexia New research from our team highlights the growing use of medications among individuals with eating disorders. Published in JAMA Psychiatry, the study found that more than half of patients… Implications of GLP-1 medications for

Currently, the long-acting GLP-1 analogues exenatide and liraglutide are being investigated as potential anti-obesity drugs, with early indications that this may indeed be worthwhile

A few comments

This does not require an intense workout consistent, moderate movement is what matters

Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol

Losing muscle is not

Unlike traditional antidiabetic drugs, GLP-1 agonists act on the brains appetite centers, leading to: Reduced hunger Smaller portion sizes Longer feeling of fullness GLP-1 Drugs15361024 256 KB Do you think GLP-1 drugs will become first-line therapy for obesity in the future or should lifestyle intervention always come first